Featuring the lost science of the 1990s, a country-wide boycott of Elsevier subscriptions, plans to help society publishers embrace Plan S and the validity of preprints
Featuring the University of California’s split from Elsevier, opinions on Plan S from the Global South and the academic community and the rise in pharma research published open access
Featuring changes to clinical trial reporting and data sharing regulations, and criticism of Plan S from the perspective of highly selective subscription journals
Featuring a summary of the findings from the COMPare study, the success of transparent peer review pilot schemes and alternative methods for measuring academic career progression
Featuring a fresh analysis of predatory publishing criteria, the development of an open access switchboard and a summary of feedback on Plan S
Last week’s ISMPP-U webinar ‘Open Access and Medical Publishing’, developed by the Medical Publishing Insights & Practices (MPIP) initiative and Open Pharma and moderated by LaVerne Mooney (Pfizer) and Chris Winchester (Oxford PharmaGenesis), aimed to define the key elements of open access policies, to provide insight into the changing publishing environment and to understand the perspectives of non-commercial and commercial stakeholders on open access publishing.
Featuring proposals from Plan U, a call for stronger open access policies in the UK, the launch of UCL’s ‘megajournal’ and Elsevier’s controversial role in monitoring Europe’s open science movement.
Featuring highlights from the European Meeting of ISMPP, discrepancies in disclosure reporting and the time implications of introducing a data availability statement.
Featuring updates from the Open Pharma round table, the expansion of transparent peer review workflows and potential problems for scientific societies with Plan S compliance.
Featuring the financial lure towards predatory publishing, an editorial mass migration and the rise of open data sets.